First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies.

IF 10.1 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2024-11-19 DOI:10.1002/ajh.27524

Francesco Autore, A Tedeschi, G Benevolo, V Mattiello, E Galli, N Danesin, R Rizzi, J Olivieri, E Cencini, B Puccini, I Ferrarini, D Marino, M Bullo, B Rossini, M Motta, I Innocenti, A Fresa, L Stirparo, D Petrilli, R Pasquale, P Musto, G Scapinello, A Noto, V Peri, G Zamprogna, S Hohaus, A M Frustaci, F Piazza, S Ferrero, L Laurenti

引用次数: 0

查看原文本刊更多论文

意大利瓦尔登斯特伦巨球蛋白血症的一线治疗：一项针对 547 名患者的多中心实际研究，旨在评估不同化学免疫疗法策略的长期疗效和耐受性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.